通过-DNA复杂武装的免疫原生细胞外囊来定制血管-免疫平衡,用于胰腺癌免疫疗法
Xue Jiang1,2, Lihuan Shang1,2, Xiaochun Chen1,2
1Guangdong Provincial Key Laboratory of Malignant Tumor Epigenetics and Gene Regulation, Guangdong-Hong Kong Joint Laboratory for RNA medicine, Sun Yat-sen Memorial Hospital, State Key Laboratory of Oncology in South China, Sun Yat-sen University, Guangzhou, 510120, China.
Advanced science (Weinheim, Baden-Wurttemberg, Germany)
|October 22, 2025
概括
装有-DNA复合体的工程外细胞囊激活树突细胞,通过重编程瘤微环境,增强胰腺癌模型中的抗瘤免疫力.
科学领域:
- 免疫学 免疫学 免疫学
- 癌症生物学 癌症生物学
- 纳米技术纳米技术
背景情况:
- 胰腺瘤会产生一种免疫抑制的环境,阻碍抗瘤免疫力.
- 树突细胞 (DCs) 中的cGAS-STING DNA感知通路对于免疫至关重要,但在胰腺癌中激活具有挑战性.
- (Mn2+) 可以增强cGAS灵敏度,但它在DNA复合体中的确切作用需要澄清.
研究的目的:
- 开发一种新的策略,使用封装在DC衍生的细胞外囊泡 (EVs) 中的-DNA复合体来激活cGAS-STING通路并增强抗瘤免疫力.
- 研究Mn2+和DNA复合体在DC中激活cGAS的机制.
- 在临床前胰腺癌模型中评估这些工程EV (EVDC@Mn-DNA) 的治疗潜力.
主要方法:
- 使用Raft-Ultra方法开发EVDC@Mn-DNA,将Mn-DNA复合物加载到由瘤溶解酸脉冲DC衍生的EV中.
- 在体外和体内评估cGAS-STING通路激活在DCs在EVDC@Mn-DNA治疗后.
- 在 орто型胰腺癌模型中评估瘤血管功能,免疫细胞透和瘤生长抑制.
主要成果:
- Mn2+诱导Z-DNA的形成,增强cGAS的结合和激活.
- EVDC@Mn-DNA有效地将Mn-DNA复合物传递给DC,从而激活cGAS-STING通路.
- 用EVDC@Mn-DNA治疗改善了血管功能 (增加血流,输液;减少缺氧),增强了抗PD-L1的输送,并促进了T细胞粘附.
- 观察到内DC和T细胞增加,三级淋巴体结构更大,瘤生长抑制.
结论:
- EVDC@Mn-DNA是一个有前途的策略,用于重新编程内直流体并恢复血管免疫平衡.
- 这种方法增强了抗瘤免疫力,并抑制了胰腺瘤的生长.
- 这些发现突显了工程电动汽车在癌症免疫治疗中的治疗潜力.
更多相关视频
08:02In Vivo Immunogenicity Screening of Tumor-Derived Extracellular Vesicles by Flow Cytometry of Splenic T Cells
Published on: September 23, 2021
3.0K
07:55Flow Cytometry-Based Isolation and Therapeutic Evaluation of Tumor-Infiltrating Lymphocytes in a Mouse Model of Pancreatic Cancer
Published on: January 17, 2025
1.7K
相关概念视频
Tumor Immunotherapy
1.7K
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
1.7K
Mesenchymal Stem Cells
5.5K
Mesenchymal stem cells (MSCs) are adult stem cells that can differentiate into most connective tissue cell types, except for hematopoietic cells, depending upon the source of MSCs. For example, bone-marrow-derived MSCs (BM-MSCs) can differentiate into osteocytes, hepatocytes, and pancreatic and neuronal cells. MSCs can be isolated from various sources such as bone marrow, placenta, adipose tissue, teeth, and Wharton’s jelly, a gelatinous substance in the umbilical cord. The ease of their...
5.5K
